MarketPulse — Real-Time Financial News & Market Analysis

Three dividend and growth stocks—ADP, American Water Works, and PayPal—trade near 52-week lows, offering potential value opportunities despite current market pressures and sector headwinds.

Mereo BioPharma faces securities lawsuit for allegedly making false statements about setrusumab trial results, causing artificially inflated stock prices and investor losses.

Whirlpool's board authorized a $0.90 quarterly dividend per share, payable March 26, 2026, reflecting continued shareholder capital returns amid competitive market operations.

AI stocks like Nvidia and Amazon offer attractive entry points as valuations stabilize. Both companies maintain strong analyst support amid significant AI infrastructure investments.

F5 investors have until Feb. 17, 2026, to join securities class action over allegedly misleading statements regarding revenue outlook and undisclosed security incidents.

GlobalFoundries and Renesas form multi-billion dollar alliance to boost semiconductor production capacity across US, Europe, and Asia starting mid-2026, targeting automotive and industrial markets.

REGENXBIO faces securities fraud lawsuit for allegedly making false statements about RGX-111 safety while withholding adverse trial data from investors between February 2022 and January 2026.

U.S. stocks lag international markets in 2025, with foreign equities surging 40% versus S&P 500's 15% gain, signaling a major reversal after a decade of U.S. dominance.

Nidec's stock plunges 22.7% after announcing accounting irregularities at its China unit. Class action litigation launched investigating potential securities law violations and shareholder damages.

Duolingo reaches $1B revenue milestone with 50M daily users, driven by AI integration and strong margins, though stock faces volatility amid growth reassessment.

Varonis Systems faces securities lawsuit alleging false revenue projection statements. Investors who purchased stock February-October 2025 may be eligible for claims by March 9, 2026 deadline.

Live Nation reports Q4 earnings February 19 amid antitrust scrutiny and high valuation concerns, despite strong 2026 bookings and recent profitability gains.

UniQure faces class action lawsuit over alleged FDA disclosure misrepresentations. Investors have until April 13, 2026 deadline to join litigation.

Sealed Air declares $0.20 quarterly dividend per share, payable March 27, 2026. The move reflects management confidence in the company's financial strength and capital allocation strategy.

Myriad Genetics reports 2025 results February 23, 2026, while preparing March launch of Precise MRD cancer detection product. Strong clinical data supports expansion.

IonQ leads quantum computing with 99.99% accuracy in gate fidelity. Market projected to reach $28-72 billion by 2035, though commercialization remains uncertain.

Keenan Capital acquired 3.66 million shares (16.08% stake) in Clearwater Analytics for $88.3 million. The move comes amid strong revenue growth and an $8.4 billion acquisition deal.

Avient's Board declared a $0.275 quarterly dividend per share, payable April 3, 2026, reflecting management confidence in the company's financial strength.

Amazon and American Express, both Berkshire holdings, offer distinct value opportunities. Amazon faces AI spending concerns but shows growth; Amex benefits from consumer spending and dividend strength.

PomDoctor Ltd. faces securities lawsuit alleging false statements, social media manipulation, and insider selling. Investors who bought stock October-December 2025 must act before April 7, 2026 deadline.